| Literature DB >> 24367503 |
Ravi Goyal1, Jonathan Van Wickle2, Dipali Goyal2, Nathanael Matei2, Lawrence D Longo1.
Abstract
In humans and other species, long-term hypoxia (LTH) during pregnancy can lead to intrauterine growth restriction with reduced body/brain weight, dysregulation of cerebral blood flow (CBF), and other problems. To identify the signal transduction pathways and critical molecules, which may be involved in acclimatization to high altitude LTH, we conducted microarray with advanced bioinformatic analysis on carotid arteries (CA) from the normoxic near-term ovine fetus at sea-level and those acclimatized to high altitude for 110+ days during gestation. In response to LTH acclimatization, in fetal CA we identified mRNA from 38 genes upregulated >2 fold (P<0.05) and 9 genes downregulated >2-fold (P<0.05). The major genes with upregulated mRNA were SLC1A3, Insulin-like growth factor (IGF) binding protein 3, IGF type 2 receptor, transforming growth factor (TGF) Beta-3, and genes involved in the AKT and BCL2 signal transduction networks. Most genes with upregulated mRNA have a common motif for Pbx/Knotted homeobox in the promoter region, and Sox family binding sites in the 3' un translated region (UTR). Genes with downregulated mRNA included those involved in the P53 pathway and 5-lipoxygenase activating proteins. The promoter region of all genes with downregulated mRNA, had a common 49 bp region with a binding site for DOT6 and TOD6, components of the RPD3 histone deacetylase complex RPD3C(L). We also identified miRNA complementary to a number of the altered genes. Thus, the present study identified molecules in the ovine fetus, which may play a role in the acclimatization response to high-altitude associated LTH.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24367503 PMCID: PMC3867347 DOI: 10.1371/journal.pone.0082200
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Top upregulated genes in high altitude acclimatized ovine fetal carotid arteries compared to normal control.
| Symbol | Entrez Gene Name | Fold Change | FH Mean | FH SD | FN Mean | FN SD | p-value |
| SLC16A3 | Solute carrier family 16, member 3 (monocarboxylic acid transporter 4) | 6.866 | 0.38 | 0.28 | 0.06 | 0.03 | 1.77E-02 |
| TNC | Tenascin C | 5.704 | 4.72 | 3.49 | 0.83 | 0.38 | 2.47E-02 |
| IGFBP3 | Insulin-like growth factor binding protein 3 | 5.288 | 1.20 | 0.12 | 0.23 | 0.13 | 3.04E-02 |
| TP53I11 | Tumor protein p53 inducible protein 11 | 5.133 | 0.13 | 0.08 | 0.03 | 0.02 | 4.46E-02 |
| IGF2R | Insulin-like growth factor 2 receptor | 4.906 | 0.59 | 0.41 | 0.12 | 0.04 | 2.99E-02 |
| ATF3 | Activating transcription factor 3 | 4.384 | 0.43 | 0.14 | 0.10 | 0.05 | 1.82E-02 |
| SERPINH1 | Serpin peptidase inhibitor, clade H (HSP47; collagen binding protein 1) | 4.246 | 12.89 | 5.76 | 3.03 | 0.92 | 1.13E-02 |
| PIM2 | Pim-2 oncogene | 3.489 | 0.07 | 0.01 | 0.02 | 0.01 | 3.40E-03 |
| DCAF8 | DDB1 and CUL4 associated factor 8 | 3.374 | 0.45 | 0.22 | 0.13 | 0.06 | 3.13E-02 |
| TGFB3 | Transforming growth factor, beta 3 | 2.919 | 1.43 | 0.50 | 0.49 | 0.26 | 4.56E-02 |
| MYOT | Myotilin | 2.789 | 5.77 | 1.12 | 2.07 | 0.46 | 3.98E-03 |
| DNAJC21 | DnaJ (Hsp40) homolog, subfamily C, member 21 | 2.613 | 0.23 | 0.05 | 0.09 | 0.03 | 1.38E-02 |
| CRELD2 | Cysteine-rich with EGF-like domains 2 | 2.597 | 0.43 | 0.16 | 0.17 | 0.02 | 4.07E-02 |
| BCL2 | B-cell CLL/lymphoma 2 | 2.549 | 0.85 | 0.24 | 0.33 | 0.16 | 4.83E-02 |
| GNL1 | Guanine nucleotide binding protein-like 1 | 2.52 | 0.35 | 0.10 | 0.14 | 0.06 | 4.20E-02 |
| HR | Hairless homolog (mouse) | 2.499 | 0.17 | 0.02 | 0.07 | 0.02 | 9.53E-03 |
| SNRNP70 | Small nuclear ribonucleoprotein 70 kDa (U1) | 2.485 | 1.12 | 0.46 | 0.45 | 0.10 | 3.78E-02 |
| ATF6B | Activating transcription factor 6 beta | 2.386 | 0.29 | 0.10 | 0.12 | 0.04 | 3.48E-02 |
| SURF6 | Surfeit 6 | 2.351 | 0.21 | 0.06 | 0.09 | 0.04 | 4.88E-02 |
| KDM4A | Lysine (K)-specific demethylase 4A | 2.327 | 0.42 | 0.11 | 0.18 | 0.04 | 1.17E-02 |
| ACTN1 | Actinin, alpha 1 | 2.326 | 23.45 | 2.57 | 10.08 | 1.35 | 1.24E-03 |
| DYNC1H1 | Dynein, cytoplasmic 1, heavy chain 1 | 2.307 | 3.16 | 0.49 | 1.37 | 0.53 | 4.59E-02 |
| MED16 | Mediator complex subunit 16 | 2.264 | 0.14 | 0.05 | 0.06 | 0.02 | 4.97E-02 |
| ADIPOR1 | Adiponectin receptor 1 | 2.247 | 0.39 | 0.08 | 0.17 | 0.05 | 2.31E-02 |
| DNAJB5 | DnaJ (Hsp40) homolog, subfamily B, member 5 | 2.247 | 1.24 | 0.47 | 0.55 | 0.12 | 4.20E-02 |
| MTMR2 | Myotubularin related protein 2 | 2.231 | 0.22 | 0.08 | 0.10 | 0.03 | 4.78E-02 |
| MTCH1 | Mitochondrial carrier 1 | 2.224 | 5.12 | 1.75 | 2.30 | 0.35 | 3.63E-02 |
| CDV3 | CDV3 homolog (mouse) | 2.206 | 0.46 | 0.15 | 0.21 | 0.07 | 4.51E-02 |
| KHSRP | KH-type splicing regulatory protein | 2.153 | 0.27 | 0.07 | 0.13 | 0.02 | 1.34E-02 |
| RBM42 | RNA binding motif protein 42 | 2.153 | 1.91 | 0.50 | 0.89 | 0.30 | 3.58E-02 |
| ATG4B | ATG4 autophagy related 4 homolog B (S. cerevisiae) | 2.119 | 1.46 | 0.46 | 0.69 | 0.10 | 3.55E-02 |
| WASF2 | WAS protein family, member 2 | 2.054 | 0.40 | 0.09 | 0.19 | 0.05 | 1.88E-02 |
| COL18A1 | Collagen, type XVIII, alpha 1 | 2.05 | 6.00 | 0.60 | 2.93 | 0.54 | 1.45E-02 |
| PLXNB1 | Plexin B1 | 2.047 | 0.56 | 0.10 | 0.27 | 0.09 | 4.24E-02 |
| COX7B | Cytochrome c oxidase subunit VIIb | 2.045 | 0.64 | 0.15 | 0.31 | 0.09 | 3.01E-02 |
| ANXA11 | Annexin A11 | 2.026 | 0.93 | 0.21 | 0.46 | 0.16 | 4.46E-02 |
| FADS2 | Fatty acid desaturase 2 | 2.023 | 0.59 | 0.20 | 0.29 | 0.06 | 4.68E-02 |
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 2.019 | 5.00 | 0.52 | 2.48 | 0.52 | 1.41E-02 |
Top downregulated genes in high altitude acclimatized fetal carotid arteries compared to normal control.
| Symbol | Entrez Gene Name | Fold Change | FH Mean | FH SD | FN Mean | FN SD | p-value |
| BRB/BRN-2 | Brain Ribonucleas | −3.63 | 4.10 | 0.73 | 14.91 | 6.33 | 0.01 |
| ALOX5AP | Arachidonate 5-lipoxygenase-activating protein | −3.247 | 0.11 | 0.03 | 0.37 | 0.04 | 0.007 |
| RNASE6 | Ribonuclease, RNase A family, k6 | −2.924 | 0.38 | 0.04 | 1.12 | 0.44 | 0.039 |
|
| T cell receptor alpha locus | −2.625 | 0.11 | 0.04 | 0.30 | 0.11 | 0.023 |
| CRABP2 | Cellular retinoic acid binding protein 2 | −2.584 | 0.16 | 0.07 | 0.42 | 0.08 | 0.039 |
| RPL35 | Ribosomal protein L35 | −2.257 | 1.87 | 0.19 | 4.21 | 0.42 | 0.003 |
| RGS10 | Regulator of G-protein signaling 10 | −2.123 | 0.16 | 0.06 | 0.34 | 0.07 | 0.043 |
| BATF3 | Basic leucine zipper transcription factor, ATF-like 3 | −2.096 | 0.10 | 0.03 | 0.20 | 0.06 | 0.038 |
| FAM35A | Family with sequence similarity 35, member A | −2.008 | 0.30 | 0.06 | 0.59 | 0.11 | 0.013 |
Chief Functional and Canonical Pathways Altered by Long-Term Hypoxia.
| Functional Pathways | Molecules |
| Cell Survival | ATF3, ATG4B, IGF2R, ADIPOR1, BCL2, DYNC1H1, AKT1, CRABP2, RGS10, IGFBP3, TGFB3, PLXNB1, COL18A1, |
| Cellular Development | ATF3, TNC, IGF2R, BCL2, DYNC1H1, AKT1, BATF3, RGS10, TGFB3, IGFBP3, PLXNB1, WASF2, COL18A1, |
| Cellular Growth and Proliferation | ATF3, TNC, SURF6, TP53I11, MTCH1, HR, ADIPOR1, IGF2R, BCL2, DYNC1H1, AKT1, ANXA11, SERPINH1, CRABP2, TGFB3, FADS2, IGFBP3, PLXNB1, WASF2, COL18A1, ACTN1, |
| Cell Morphology | ATF3, TNC, AKT1, SERPINH1, ATG4B, TGFB3, IGFBP3, WASF2, COL18A1, |
| Cardiovascular System Development and Function | TNC, ATF3, AKT1, SERPINH1, TGFB3, IGFBP3, PLXNB1, WASF2, COL18A1, IGF2R, PIM2, BCL2 |
| Hematological System Development and Function | TNC, ATF3, AKT1, BATF3, RGS10, PLXNB1, WASF2, IGF2R, |
|
|
|
| VEGF Signaling | AKT1,ACTN1,BCL2 |
| PTEN Signaling | AKT1, IGF2R, BCL2 |
| PI3K Signaling in B Lymphocytes | AKT1, ATF3, ATF6B |
| TGF-β Signaling | TGFB3, BCL2 |
| PI3K/AKT Signaling | AKT1, BCL2 |
Figure 1Demonstrates the network of genes in ovine fetal carotid arteries extra-cellular, plasma membrane, cytoplasm, and nucleus altered as a consequence of antenatal maternal long-term hypoxia.
Red color represents the upregulated genes; the higher intensity of color denotes greater fold-change; green represents the downregulated genes.
Figure 2Demonstrates protein expression of (A) AKT and (B) IGFBP3. N = 4 in each group; Total extracellular regulated kinase (TERK) served as an internal control to which AKT and IGFBP3 were normalized to provide relative integrated density (IDV).
* Denotes significant changes in protein expression by Students t-test (P<0.05); FN - Carotid arteries from control (normoxic) fetus, FH - Carotid arteries from antenatal long-term hypoxia acclimatized animals.
Figure 3Demonstrates immunohistochemistry images of PKNOX1 expression in carotid arteries from normoxic fetus (FN) and hypoxic fetuses (FH).
*Denotes statistically significant difference by Students t-test (P<0.05).
Figure 4Demonstrates a common motif in 1800 base pairs upstream to the transcription start site of the upregulated genes.
Strand + and − denotes the sense and antisense DNA sequence. The start denotes the number of base pair upstream to the transcriptional start site. p-value denotes the probability of the presence of motif by chance in the given sequence as a part of group of sequence altered by long-term hypoxic exposure. The bottom of the figure shows a cis-regulatory element for Pbx/knotted 1 homeobox transcription factor, which can bind on the common motif of the genes shown above. Bits refer to the likely hood of the presence of a particular letter of a specific motif, at a specific site, in more number of background sequences of genes altered by long-term hypoxia.
Figure 5Demonstrates a common motif in 1800 base pairs upstream to the transcription start site of the downregulated genes.
The bottom of the figure shows a cis-regulatory element for TOD6/DOT6 transcription factor, which can bind on the common motif of the genes shown above.
Figure 6Demonstrates a common motif in the 3′ untranslated region of the upregulated genes.
The bottom of the figure shows a cis-regulatory element for Sox family transcription factors, which can bind on the common motif of the genes shown above.